B3GALT2 rs551911: Understanding Your Genetic Association
The rs551911 variant is a non-coding genetic change located within the B3GALT2 gene region. It has been identified in scientific research as a potential risk factor associated with age-related macular degeneration (AMD).
What each genotype means
Baseline Macular Degeneration Risk
Research indicates that individuals with two copies of the G allele have the typical baseline population risk associated with the B3GALT2 locus for age-related macular degeneration. Studies show this genotype does not carry the increased risk observed with the alternative allele. However, age-related macular degeneration is a complex condition influenced by multiple genetic and lifestyle factors.
Found in approximately 55% to 70% of individuals across European and East Asian populations.
Modestly Increased AMD Risk
Carrying one copy of the A allele at rs551911 has been associated with a modest increase in the risk of developing age-related macular degeneration compared to the baseline genotype. The overall evidence linking this non-coding B3GALT2 variant to disease risk is limited and reflects statistical associations rather than a definitive diagnosis. Lifestyle factors, such as diet and smoking, alongside broader genetic profiles, also play substantial roles.
Carried by roughly 30% to 40% of individuals in European and East Asian populations.
Elevated Macular Degeneration Risk
Individuals with two copies of the A allele carry the highest relative genetic risk associated with the rs551911 variant for age-related macular degeneration in reported GWAS studies. While this non-coding change at the B3GALT2 locus demonstrates a statistically significant correlation with AMD, the variant has limited overall clinical evidence on its own. This result describes an elevated statistical predisposition rather than a guarantee of disease.
Found in approximately 2% to 6% of people of European and East Asian descent.
What is rs551911?
The identifier rs551911 refers to a specific single nucleotide polymorphism (SNP) in the human genome. A SNP is a variation at a single position in a DNA sequence among individuals. This particular variant is classified as non-coding, meaning it does not reside within the protein-coding sequence of a gene that provides instructions for building a protein. Instead, it sits in the regulatory or intergenic regions of the genome, where it may influence how nearby genes are expressed or regulated. In the case of rs551911, it is mapped to the locus of the B3GALT2 gene. Researchers use these markers to track inheritance patterns and identify regions of the genome that may contribute to complex traits or health conditions through large-scale statistical analyses known as genome-wide association studies (GWAS).
The Role of B3GALT2
The B3GALT2 gene encodes a protein known as beta-1,3-galactosyltransferase 2. This enzyme is part of a family of proteins involved in glycosylation, a process where sugar molecules are attached to proteins or lipids. Glycosylation is essential for the proper structure and function of many cellular components, including those found in the eye. While the specific biological mechanism linking this gene to eye health is still being investigated, the presence of genetic variants in this region suggests that variations in how these enzymes function or are regulated could potentially influence the maintenance of retinal tissues. Understanding the function of B3GALT2 is a focus of ongoing research to determine how it might interact with other genetic and environmental factors to influence the risk of developing age-related conditions.
Research and Evidence Strength
The association between rs551911 and age-related macular degeneration (AMD) is based on findings from genome-wide association studies. AMD is a complex, multifactorial condition that affects the macula, the part of the retina responsible for sharp central vision. While some studies have highlighted this locus as a significant risk factor, the evidence strength for this specific variant is currently considered limited. This means that while statistical correlations have been observed in certain cohorts, the biological causality is not fully established. Furthermore, genetic associations can vary significantly between different ancestral groups. Because AMD is influenced by a combination of genetics, age, lifestyle, and environmental factors, a single SNP like rs551911 provides only a small piece of a much larger, complex puzzle regarding an individual's overall health profile.
Population Frequency
Genetic variants are distributed differently across global populations, and rs551911 is no exception. Research indicates that this is a common variant, particularly within European and East Asian populations. In these groups, the minor allele frequency (MAF) typically ranges between 15% and 25%. This frequency suggests that a significant portion of the population carries at least one copy of the variant allele. Because it is common, it is considered a standard variation rather than a rare mutation. However, the prevalence of the variant does not necessarily dictate its impact on health; rather, it highlights that many people carry this genetic marker without experiencing the condition it is associated with. Population-specific studies are crucial for understanding how these frequencies correlate with disease risk in diverse groups.
Interpreting Your Results
If you have received information about your rs551911 genotype, it is important to view it within the context of current scientific understanding. This variant is a statistical marker, not a diagnostic tool. Having a specific genotype does not mean you will develop a condition, nor does the absence of it guarantee protection. Genetic risk is only one factor in the development of complex conditions like AMD, which are also heavily influenced by age, smoking status, diet, and other environmental exposures. You cannot use this information to diagnose yourself or predict your future health with certainty. If you have concerns about your vision or your risk for eye disease, the most appropriate step is to consult with an eye care professional, such as an ophthalmologist or optometrist, who can provide personalized clinical assessments and guidance.
How common is this variant?
The rs551911 variant is a common polymorphism with a minor allele frequency of approximately 15-25% in European and East Asian populations.
Frequently asked questions
Is rs551911 a diagnostic test for macular degeneration?
No, rs551911 is not a diagnostic test. It is a genetic marker identified in research studies that shows a statistical association with risk, but it cannot predict whether an individual will develop the condition.
What should I do if I have the risk-associated genotype?
You should continue to follow standard health recommendations, such as scheduling regular comprehensive eye exams with an eye care professional. Genetic markers are only one part of your overall health profile and should not be used to make medical decisions.
Does this variant affect everyone the same way?
No, genetic associations can vary based on ancestry and the presence of other genetic or environmental factors. The impact of a single variant is rarely uniform across different individuals or populations.
Where can I find more information on AMD risk?
You can find reliable information on age-related macular degeneration through organizations like the National Eye Institute or the American Academy of Ophthalmology. These resources provide evidence-based information on symptoms, risk factors, and eye health.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs551911?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29